Mutations of the BRAF gene in human cancer, by Davies et al. (Nature 2002; 417: 949-54)

Clinical and Experimental Dermatology

Volumn 38, Issue 2, 2013, Pages 222-223

  Millington, G W M ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CORTICOTROPIN; DACARBAZINE; MELANOCORTIN 1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN; VEMURAFENIB;

BASAL CELL CARCINOMA; CANCER GENETICS; CARCINOGENESIS; CARCINOMA; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CLINICAL TRIAL (TOPIC); GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LENTIGO; MELANOMA; NOTE; PRIORITY JOURNAL; RADIATION EXPOSURE; SKIN CELL; SOMATIC MUTATION; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; ULTRAVIOLET RADIATION;

ANIMALS; HUMANS; MELANOMA; MUTATION, MISSENSE; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-RAF;

EID: 84873672326     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12015     Document Type: Note

References (6)

1. Davies H, Bignell GR, Cox C, et al,. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949-54. (Pubitemid 34716871)
2. Besaratinia A, Pfeifer GP,. Sunlight ultraviolet irradiation and BRAF V600 mutagenesis in human melanoma. Hum Mutat 2008; 29: 983-91.
3. De Luca AM, Srinivas A, Alani RM,. BRAF kinase in melanoma development and progression. Expert Rev Mol Med 2009; 10: e6.
4. Millington GWM,. Proopiomelanocortin (POMC): the cutaneous roles of its melanocortin products and receptors. Clin Exp Dermatol 2006; 31: 407-12.
5. Landi MT, Bauer J, Pfeiffer RM, et al,. MC1R germline variants confer risk for BRAF-mutant melanoma. Science 2006; 313: 521-2. (Pubitemid 44148456)
6. Chapman PB, Hauschild A, Robert C, et al,. Improved survival with vemurafenib in melanoma with BRAF V600E mutations. N Engl J Med 2011; 364: 2517-26.